Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaUlrich Mey, Ingo G.H. Schmidt‐Wolf, Anthony D. Ho et al.|Cancer Investigation|2006Cited by 61
A Phase II Trial of Dexamethasone, High-Dose Cytarabine, and Cisplatin (DHAP) in Combination with Rituximab as Salvage Treatment for Patients with Refractory or Relapsed Aggressive Non-Hodgkin’s Lymphoma.Ulrich Mey, Ingo G.H. Schmidt‐Wolf, John Strehl et al.|Blood|2004Cited by 3